BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ichida H, Imamura H, Yoshimoto J, Sugo H, Kajiyama Y, Tsurumaru M, Suzuki K, Ishizaki Y, Kawasaki S. Pattern of Postoperative Recurrence and Hepatic and/or Pulmonary Resection for Liver and/or Lung Metastases From Esophageal Carcinoma. World J Surg 2013;37:398-407. [DOI: 10.1007/s00268-012-1830-7] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Liu Q, Zhu Z, Chen Y, Deng J, Ai D, Liu Q, Wang S, Wu S, Chen J, Zhao K. Phase 2 Study of Stereotactic Body Radiation Therapy for Patients with Oligometastatic Esophageal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics 2020;108:707-15. [DOI: 10.1016/j.ijrobp.2020.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zhou F, Yu X, Liang P, Cheng Z, Han Z, Yu J, Liu F, Tan S, Dai G, Bai L. Combined microwave ablation and systemic chemotherapy for liver metastases from oesophageal cancer: Preliminary results and literature review. International Journal of Hyperthermia 2016;32:524-30. [DOI: 10.3109/02656736.2016.1155758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
3 Wen D, Collantes E, Sgromo B. Oligometastatic recurrence of an oesophageal adenocarcinoma at a chest drain site following radical treatment: palliative treatment or resection? Clin J Gastroenterol 2018;11:470-5. [PMID: 30145768 DOI: 10.1007/s12328-018-0890-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Yago A, Ohkura Y, Ueno M, Fujisawa K, Ogawa Y, Shimoyama H, Haruta S, Udagawa H. Importance of long-term surveillance after curative esophagectomy for esophageal squamous cell carcinoma. Dis Esophagus 2022:doab098. [PMID: 35032162 DOI: 10.1093/dote/doab098] [Reference Citation Analysis]
5 Yamanashi K, Hamaji M, Tsunoda S, Nakanishi T, Omasa M, Nakajima N, Ohsumi A, Menju T, Chen-Yoshikawa TF, Date H. Survival outcomes of resection for pulmonary malignancies including non-small cell lung cancer and pulmonary metastasis after esophagectomy for esophageal carcinoma. Gen Thorac Cardiovasc Surg 2020;68:1179-86. [PMID: 32361810 DOI: 10.1007/s11748-020-01373-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ai D, Chen Y, Liu Q, Deng J, Zhao K. The effect of tumor locations of esophageal cancer on the metastasis to liver or lung. J Thorac Dis 2019;11:4205-10. [PMID: 31737304 DOI: 10.21037/jtd.2019.09.67] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fonseca GM, Braghiroli MIFM, Pirola Kruger JA, Coelho FF, Herman P. Is There a Role for Locoregional Therapies for Non-colorectal Gastrointestinal Malignancies? Surg Oncol Clin N Am 2021;30:125-42. [PMID: 33220801 DOI: 10.1016/j.soc.2020.08.004] [Reference Citation Analysis]
8 Beckert S, Königsrainer A. Oligometastasierung beim Magen- und Ösophaguskarzinom: Aktuelle Studienlage und chirurgische Konzepte. Chirurg 2018;89:505-9. [DOI: 10.1007/s00104-018-0645-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Schmidt T, Mönig SP. [Therapeutic approach in oligometastatic gastric and esophageal cancer]. Chirurg 2017;88:1024-32. [PMID: 29098307 DOI: 10.1007/s00104-017-0548-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
10 Wang Y, Zhang W, Chang X, Cao F, Yu H, Xing W, Yang X, Guo Z. CT-guided percutaneous cryoablation combined with systemic chemotherapy for liver metastases from esophageal carcinoma: Initial experience. Cryobiology 2019;87:99-104. [DOI: 10.1016/j.cryobiol.2019.01.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Takemura N, Saiura A. Role of surgical resection for non-colorectal non-neuroendocrine liver metastases. World J Hepatol 2017; 9(5): 242-251 [PMID: 28261381 DOI: 10.4254/wjh.v9.i5.242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
12 Macherey S, Preuss SF, Doerr F, Grönke S, Heldwein M, Quaas A, Zander T, Hekmat K. [Surgical therapy of lung metastases from head and neck cancer]. HNO 2014;62:893-901; quiz 902-3. [PMID: 25294229 DOI: 10.1007/s00106-014-2933-2] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Taniyama Y, Sakurai T, Hikage M, Okamoto H, Sato C, Takaya K, Unno M, Kamei T. How does presurgical chemotherapy influence the efficiency of treatment for esophageal cancer recurrence after curative esophagectomy? Thorac Cancer 2019;10:769-74. [PMID: 30756477 DOI: 10.1111/1759-7714.12996] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Procopio F, Marano S, Gentile D, Da Roit A, Basato S, Riva P, De Vita F, Torzilli G, Castoro C. Management of Liver Oligometastatic Esophageal Cancer: Overview and Critical Analysis of the Different Loco-Regional Treatments. Cancers (Basel) 2019;12:E20. [PMID: 31861604 DOI: 10.3390/cancers12010020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
15 Kroese TE, van Laarhoven HWM, Nilsson M, Lordick F, Guckenberger M, Ruurda JP, D'Ugo D, Haustermans K, van Cutsem E, van Hillegersberg R, van Rossum PSN. Definition of oligometastatic esophagogastric cancer and impact of local oligometastasis-directed treatment: A systematic review and meta-analysis. Eur J Cancer 2022;166:254-69. [PMID: 35339868 DOI: 10.1016/j.ejca.2022.02.018] [Reference Citation Analysis]
16 Schizas D, Lazaridis II, Moris D, Mastoraki A, Lazaridis LD, Tsilimigras DI, Charalampakis N, Liakakos T. The role of surgical treatment in isolated organ recurrence of esophageal cancer-a systematic review of the literature. World J Surg Oncol 2018;16:55. [PMID: 29540179 DOI: 10.1186/s12957-018-1357-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
17 Schizas D, Mylonas KS, Kapsampelis P, Bagias G, Katsaros I, Frountzas M, Hemmati P, Liakakos T. Patients undergoing surgery for oligometastatic oesophageal cancer survive for more than 2 years: bootstrapping systematic review data. Interactive CardioVascular and Thoracic Surgery 2020;31:299-304. [DOI: 10.1093/icvts/ivaa116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kanzaki R, Kimura T, Kawamura T, Funaki S, Shintani Y, Minami M, Yamasaki M, Mori M, Doki Y, Okumura M. Surgery for malignant pulmonary nodules in patients with a history of oesophageal cancer. Interact Cardiovasc Thorac Surg 2017;24:418-24. [PMID: 28040757 DOI: 10.1093/icvts/ivw358] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Weiss ARR, Donlon NE, Schlitt HJ, Hackl C. Resection of oesophageal and oesophagogastric junction cancer liver metastases - a summary of current evidence. Langenbecks Arch Surg 2021. [PMID: 34860291 DOI: 10.1007/s00423-021-02387-3] [Reference Citation Analysis]
20 Liu Q, Chen J, Li B, Ye J, Wei S, Wang Y, Yang H, Zhu Z, Lai S, Li L, Chen Y, Wang J, Xiang J, Zhao K. Local therapy for oligometastatic esophageal squamous cell carcinoma: a prospective, randomized, Phase II clinical trial. Future Oncol 2021;17:1285-93. [PMID: 33626929 DOI: 10.2217/fon-2020-0873] [Reference Citation Analysis]
21 Jamel S, Tukanova K, Markar S. Detection and management of oligometastatic disease in oesophageal cancer and identification of prognostic factors: A systematic review. WJGO 2019;11:741-9. [DOI: 10.4251/wjgo.v11.i9.0000] [Reference Citation Analysis]
22 Liu J, Wei Z, Wang Y, Xia Z, Zhao G. Hepatic resection for post-operative solitary liver metastasis from oesophageal squamous cell carcinoma. ANZ J Surg 2018;88:E252-6. [PMID: 27764891 DOI: 10.1111/ans.13810] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
23 Miyawaki Y, Sato H, Oya S, Sugita H, Hirano Y, Sakuramoto S, Okamotom K, Yamaguchim S, Koyama I. Clinical impact of abdominal versus mediastinal metastases as a prognostic factor for poor outcomes following esophageal cancer surgery: a retrospective study. BMC Cancer 2021;21:725. [PMID: 34162359 DOI: 10.1186/s12885-021-08484-2] [Reference Citation Analysis]
24 Wu SG, Zhang WW, Sun JY, Li FY, Lin Q, He ZY. Patterns of Distant Metastasis Between Histological Types in Esophageal Cancer. Front Oncol 2018;8:302. [PMID: 30135855 DOI: 10.3389/fonc.2018.00302] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
25 Takeuchi M, Hoshino S, Kawakubo H, Matsuda S, Mayanagi S, Irino T, Fukuda K, Nakamura R, Wada N, Kitagawa Y. Author Reflections: Relationship of Systemic Inflammatory Response Indicators at Recurrence to Long-Term Outcomes in Patients with Recurrent Esophageal Squamous Cell Carcinoma: The Utility of Neutrophil-to-Lymphocyte Ratio. Ann Surg Oncol 2021;28:3009-10. [PMID: 33651215 DOI: 10.1245/s10434-021-09638-z] [Reference Citation Analysis]
26 Kurihara T, Itoh S, Kimura Y, Oki E, Yoshizumi T, Matuo M, Yasumatsu R, Sugimachi K, Morita M, Kusumoto T, Fukuzawa K, Yoshida N, Baba H, Mori M. Feasibility of hepatic resection for liver metastasis of head-and-neck carcinoma or esophageal carcinoma: a multi-center experience. Surg Today 2021. [PMID: 34032927 DOI: 10.1007/s00595-021-02305-6] [Reference Citation Analysis]
27 Yamashita K, Watanabe M, Mine S, Kurogochi T, Okamura A, Hayami M, Imamura Y. Patterns and Outcomes of Recurrent Esophageal Cancer After Curative Esophagectomy. World J Surg 2017;41:2337-44. [PMID: 28432391 DOI: 10.1007/s00268-017-4024-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
28 Jamel S, Tukanova K, Markar S. Detection and management of oligometastatic disease in oesophageal cancer and identification of prognostic factors: A systematic review. World J Gastrointest Oncol 2019; 11(9): 741-749 [PMID: 31558978 DOI: 10.4251/wjgo.v11.i9.741] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
29 Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus. 2019;16:25-43. [PMID: 30171414 DOI: 10.1007/s10388-018-0642-8] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 29.3] [Reference Citation Analysis]
30 Tapia Rico G, Townsend AR, Klevansky M, Price TJ. Liver metastases resection for gastric and esophageal tumors: is there enough evidence to go down this path? Expert Rev Anticancer Ther. 2016;16:1219-1225. [PMID: 27744727 DOI: 10.1080/14737140.2016.1249858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
31 Rogers MP, DeSantis AJ, DuCoin CG. Oligometastatic Adenocarcinoma of the Esophagus: Current Understanding, Diagnosis, and Therapeutic Strategies. Cancers (Basel) 2021;13:4352. [PMID: 34503162 DOI: 10.3390/cancers13174352] [Reference Citation Analysis]
32 Schizas D, Vailas M, Sotiropoulou M, A Ziogas I, S Mylonas K, Katsaros I, Kapelouzou A, Liakakos T. Surgery for metachronous oligometastatic esophageal cancer: Is there enough evidence? Cir Esp 2021;99:490-9. [PMID: 33894971 DOI: 10.1016/j.ciresp.2021.03.003] [Reference Citation Analysis]
33 Souche R, Dupuy M, Fabre JM, Assenat E. Multimodal treatment including surgery for esophageal adenocarcinoma with liver oligo-metastases: a pathological complete response but early brain metastasis. Clin J Gastroenterol 2020;13:713-6. [PMID: 32347470 DOI: 10.1007/s12328-020-01127-2] [Reference Citation Analysis]
34 Huddy JR, Thomas RL, Worthington TR, Karanjia ND. Liver metastases from esophageal carcinoma: is there a role for surgical resection? Dis Esophagus. 2015;28:483-487. [PMID: 24898890 DOI: 10.1111/dote.12233] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
35 Blackham AU, H Naqvi SM, Schell MJ, Jin W, Gangi A, Almhanna K, Fontaine JP, Hoffe SE, Frakes J, Venkat P, Pimiento JM. Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancer. J Surg Oncol 2018;117:150-9. [PMID: 28833197 DOI: 10.1002/jso.24808] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
36 Schizas D, Vailas M, Sotiropoulou M, A Ziogas I, S Mylonas K, Katsaros I, Kapelouzou A, Liakakos T. Surgery for metachronous oligometastatic esophageal cancer: Is there enough evidence? Cir Esp (Engl Ed) 2021;99:490-9. [PMID: 34353590 DOI: 10.1016/j.cireng.2021.07.006] [Reference Citation Analysis]